UPLOAD Filing
MANGOCEUTICALS, INC.
Date: Jan. 27, 2026 · CIK: 0001938046 · Accession: 0000000000-26-000913
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292711
Letter
January 22, 2026 Jacob Cohen Chairman and Chief Executive Officer Mangoceuticals, Inc. 17130 N. Dallas Parkway, Suite 240 Dallas, Texas 75248 Re:Mangoceuticals, Inc. Registration Statement on Form S-1 Filed January 13, 2026 File No. 333-292711 Dear Jacob Cohen: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jane Park at 202-551-7439 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc:Steven Lipstein, Esq.
Show Raw Text
January 22, 2026
Jacob Cohen
Chairman and Chief Executive Officer
Mangoceuticals, Inc.
17130 N. Dallas Parkway, Suite 240
Dallas, Texas 75248
Re:Mangoceuticals, Inc.
Registration Statement on Form S-1
Filed January 13, 2026
File No. 333-292711
Dear Jacob Cohen:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jane Park at 202-551-7439 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and Services
cc:Steven Lipstein, Esq.